Researchers developed NZ-97, an inhalable drug that stimulates the growth of stem cells in the lungs, potentially repairing ...

Enrollment has been completed for a Phase 2b trial that’s testing LYT-100 (deupirfenidone) for adults with idiopathic ...

As columnist Ann Reynoso prepares to travel by air for the first time since her PF diagnosis, she must first manage extreme ...

Virginia's allergy season means changed routines for columnist Sam Kirton in the wake of his bilateral lung transplant.

Researchers have developed an inhalable prototype medicine that may be able to repair lung scarring caused by idiopathic pulmonary fibrosis (IPF) by stimulating the growth of stem cells directly in ...

Are you angry? If so, who are you angry with and why? I follow a number of social media groups associated with different rare disease communities. Lately, it seems that people are angry with the very ...

Last month, I wrote about my constant battle with lung infections. As a patient with idiopathic pulmonary fibrosis (IPF), a progressive and life-threatening lung disease, I think the condition’s ...

Low doses of controlled-release morphine, a natural opioid derived from the opium poppy, may reduce the frequency of daytime cough in people with idiopathic pulmonary fibrosis (IPF), according to data ...

Pliant Therapeutics’ Phase 2b BEACON-IPF trial testing bexotegrast, an investigational oral treatment, in people with idiopathic pulmonary fibrosis (IPF) is now a pivotal, adaptive Phase 2b/3 trial.